Core Viewpoint - 卓珈控股(01827) reported a decline in revenue for the six months ending September 30, with earnings of HKD 160 million, representing a year-on-year decrease of 19.99% [1] Financial Performance - The company recorded a loss attributable to ordinary equity holders of HKD 335,000, which is a reduction of 46.83% compared to the previous year [1] - Basic loss per share was HKD 0.08 [1]

Core Viewpoint - 卓珈控股 reported a revenue of HKD 160 million for the six months ending September 30, representing a year-on-year decrease of 19.99% [1] - The company recorded a loss attributable to ordinary shareholders of HKD 335,000, which is a reduction of 46.83% compared to the previous year [1] - The basic loss per share was HKD 0.08 [1] Financial Performance - Revenue for the period was HKD 160 million, down 19.99% year-on-year [1] - Loss attributable to ordinary shareholders was HKD 335,000, a decrease of 46.83% year-on-year [1] - Basic loss per share was reported at HKD 0.08 [1]

Core Viewpoint - 卓珈控股 reported a revenue of HKD 160 million for the six months ending September 30, 2025, representing a year-on-year decrease of 20% [1] - The company recorded a loss attributable to equity holders of HKD 335,000, an improvement from a loss of HKD 630,000 in the same period last year [1] - Basic loss per share was HKD 0.08 [1] Financial Performance - Revenue for the period was HKD 160 million, down 20% year-on-year [1] - Loss attributable to equity holders was HKD 335,000, compared to a loss of HKD 630,000 in the previous year [1] - Basic loss per share stood at HKD 0.08 [1]

Financial Performance - For the six months ended September 30, 2025, the group's revenue was approximately HKD 160.08 million, a decrease of about HKD 40 million or 20.0% compared to HKD 200.08 million for the same period in 2024[3] - The loss attributable to the company's owners for the six months ended September 30, 2025, was approximately HKD 0.3 million, compared to a loss of HKD 0.6 million for the same period in 2024[3] - Total revenue for the six months ended September 30, 2025, was HKD 160,080,000, a decrease of approximately HKD 40,000,000 or 20.0% compared to HKD 200,076,000 for the same period in 2024[28] - The group recorded a loss of HKD 335,000 for the six months ended September 30, 2025, compared to a loss of HKD 630,000 for the same period in 2024[20] - The company's basic and diluted loss per share for the six months ended September 30, 2025, was HKD 0.08, compared to HKD 0.16 for the same period in 2024[4] Assets and Liabilities - Total non-current assets as of September 30, 2025, amounted to HKD 132.07 million, down from HKD 156.29 million as of March 31, 2025[5] - Current assets totaled HKD 322.59 million as of September 30, 2025, compared to HKD 314.99 million as of March 31, 2025[5] - The total liabilities for current liabilities were HKD 262.67 million as of September 30, 2025, slightly down from HKD 263.85 million as of March 31, 2025[6] - The total equity as of September 30, 2025, was HKD 147.37 million, slightly down from HKD 147.56 million as of March 31, 2025[6] - Trade receivables at the end of the reporting period were HKD 2,695,000, down from HKD 3,888,000 as of March 31, 2025[22] - Trade payables at the end of the reporting period totaled HKD 9,376,000, an increase from HKD 6,336,000 as of March 31, 2025[24] Revenue Breakdown - Revenue from external customers in Hong Kong was HKD 158.85 million for the six months ended September 30, 2025, compared to HKD 195.04 million for the same period in 2024[12] - Revenue from external customers in Mainland China was HKD 1.23 million for the six months ended September 30, 2025, down from HKD 5.04 million for the same period in 2024[12] - Revenue from medical consultation services remained stable at HKD 2,000 for both periods, while revenue from skincare products decreased from HKD 29,336,000 to HKD 18,477,000[15] Expenses and Cost Management - Employee costs decreased by approximately HKD 12.1 million or 16.3% to about HKD 62.1 million during the review period, primarily due to operational efficiency improvements[30] - Property rental and related expenses reduced by approximately HKD 4.1 million or 14.2% to about HKD 24.8 million, mainly due to optimized sales network and better lease terms[31] - Other net expenses decreased by approximately HKD 12.4 million or 24.1% to about HKD 39 million, attributed to enhanced operational efficiency and effective cost control[33] - The cost of inventory and consumables for the current and prior periods was approximately HKD 22,110,000 and HKD 25,400,000, representing 13.8% and 12.7% of total revenue, respectively[29] - Depreciation of property, plant, and equipment was HKD 13,873,000 for the six months ended September 30, 2025, down from HKD 19,259,000 in 2024[16] Dividends and Shareholder Returns - The board did not declare an interim dividend for the six months ended September 30, 2025, consistent with the previous period[3] - The group did not declare any interim dividends for the six months ended September 30, 2025, consistent with the previous year[19] Strategic Outlook - The group plans to continue enhancing operational efficiency and resource allocation to maintain stability and growth amid economic uncertainties[25] - The group aims to leverage its brand strength and service quality to provide better customer experiences and greater value for stakeholders in the upcoming period[27] - The company plans to adopt a cautious and prudent operational strategy in response to structural changes in the consumer market[49] Financial Health - As of September 30, 2025, the company maintained a healthy financial position with cash and cash equivalents of approximately HKD 186.6 million[38] - The debt-to-equity ratio as of September 30, 2025, was approximately 1.7%, down from 4.0% as of March 31, 2025[43] - The company has no significant contingent liabilities or guarantees as of September 30, 2025[41] - The company has not made any significant investments or acquisitions during the review period[46] Corporate Governance - The audit committee has been established in accordance with the listing rules and corporate governance code, consisting of three independent non-executive directors[54] - The audit committee is chaired by Mr. Zheng Yuhua, who has suitable accounting and financial management expertise[54] - The financial information for the review period has not been reviewed by the independent auditor but has been reviewed by the audit committee[54] - The board of directors includes three executive directors and three independent non-executive directors as of the announcement date[55] Workforce - The company employed a total of 255 employees as of September 30, 2025, compared to 242 employees in the previous year[47]

Core Viewpoint - 卓珈控股 (01827.HK) will hold a board meeting on November 25, 2025, to approve its interim results for the six months ending September 30, 2025, and to consider the proposal for an interim dividend, if any [1] Summary by Category - **Company Announcement** - The company has scheduled a board meeting for November 25, 2025 [1] - The meeting will focus on approving the interim results for the six months ending September 30, 2025 [1] - The board will also consider the proposal for an interim dividend [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容 而引致之任何損失承擔任何責任。 董事會召開日期 卓珈控股集團有限公司（「本公司」）董事會（「董事會」）謹此宣佈，本公司將於二零二五年十一月 二十五日(星期二)舉行董事會會議，藉以 (其中包括) 批准本公司及其附屬公司截至二零二五年九月 三十日止六個月的中期業績及其刊發，以及考慮建議派發中期股息 (如有)。 承董事會命 卓珈控股集團有限公司 主席兼行政總裁 黎珈而 Miricor Enterprises Holdings Limited 卓珈控股集團有限公司 （於開曼群島註冊成立之有限公司） （股份代號：1827） 香港，二零二五年十一月十三日 於本公告日期，董事會包括三名執行董事，即黎珈而女士、何子亮先生及林秉恩醫生；和三名獨立 非執行董事，即鄭輔國先生、鄭毓和先生及李偉君先生。 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 卓珈控股集團有限公司 (「本公司」)(於開曼群島註冊成立之有限公司) 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01827 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 HKD | | 20,000,000 | 本月 ...

截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 卓珈控股集團有限公司 (「本公司」)(於開曼群島註冊成立之有限公司) 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 FF301 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01827 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 400,000,000 | | | | 400,000,000 | | 增加 / 減少 (-) | | | 0 | | | | | | 本月底結存 | | | 400,000,000 | | 0 | | 400,000,000 | 第 2 頁 共 10 頁 v 1.1.1 第 1 頁 共 10 頁 v 1.1.1 FF301 呈交日期: 2025年10月 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部 分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Miricor Enterprises Holdings Limited 卓珈控股集團有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1827） 2025年9月29日舉行之 股東週年大會投票表決結果 茲提述卓珈控股集團有限公司（「本公司」）日期為2025年7月25日的股東週年大會通 告、本公司日期為2025年7月25日的通函及本公司日期為2025年9月22日之公告。 本公司欣然宣佈於2025年9月29日舉行之本公司股東週年大會（「股東週年大會」）上 提呈之決議案的投票表決結果如下： | | 普通決議案 | | 票數(%) | | | --- | --- | --- | --- | --- | | | | | 贊成 反對 | | | 1. | | 省覽及考慮截至2025年3月31日止年度之經審核 320,130,000 | | 0 | | | | (100%) 綜合財務報表及董事會報告及獨立核數師報 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部 分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Miricor Enterprises Holdings Limited 卓珈控股集團有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1827） 由於颱風原定於2025年9月23日舉行的股東週年大會將延期 茲提述卓珈控股集團有限公司（「本公司」）日期為2025年7月25日的股東週年大會 （「股東週年大會」）通告（「股東週年大會通告」）及本公司日期為2025年7月25日的通 函（「該通函」）。除另有界定者外，本公告所用詞彙與該通函所界定者具有相同涵義。 為釐定股東出席股東週年大會並於會上投票之資格而暫停辦理股份過戶登記手續 的期間（如該通函所述）將維持不變。就股東週年大會而言，寄存於本公司的香港股 份過戶登記分處卓佳證券登記有限公司的所有代表委任表格將於經改期之股東週 年大會上維持有效。 承董事會命 卓珈控股集團有限公司 主席兼行政總裁 黎珈而 香港，2025年9月22日 於本公告日期，董事會包括三 ...